Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Single-Dose Study of RO7046015 in Healthy Japanese Men

Trial Profile

A Phase I Single-Dose Study of RO7046015 in Healthy Japanese Men

Phase of Trial: Phase I

Latest Information Update: 30 Aug 2018

At a glance

  • Drugs Prasinezumab (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Chugai Pharmaceutical; Prothena; Roche
  • Most Recent Events

    • 27 Aug 2018 Status changed from active, no longer recruiting to completed.
    • 18 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 20 Feb 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top